Biomarkers of sepsis: Lost in translation?

Critical Care Medicine

Volumn 36, Issue 7, 2008, Pages 2192-2194

  Salluh, Jorge I F ^a,b   Bozza, Patrícia T ^b  

^a Instituto Nacional de C ncer   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Biomarkers; Cytokines; Lipopolysaccharide binding protein; Outcomes; PIRO; Severe sepsis

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROCALCITONIN; ACUTE PHASE PROTEIN; CARRIER PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN;

ANTIBIOTIC THERAPY; DISEASE SEVERITY; EDITORIAL; GRAM NEGATIVE BACTERIUM; INTENSIVE CARE; INTENSIVE CARE UNIT; PRIORITY JOURNAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT DURATION; AREA UNDER THE CURVE; BLOOD; DIFFERENTIAL DIAGNOSIS; HUMAN; METHODOLOGY; NOTE;

ACUTE-PHASE PROTEINS; AREA UNDER CURVE; BIOLOGICAL MARKERS; CARRIER PROTEINS; CRITICAL CARE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MEMBRANE GLYCOPROTEINS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 47249102596     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31817c0cd8     Document Type: Editorial

References (15)

1. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
2. Gerlach H, Dhainaut JF, Harbarth S, et al: The PIRO concept: R is for response. Crit Care 2003; 7:256-259
3. Bozza FA, Bozza PT, Castro Faria Neto HC: Beyond sepsis pathophysiology with cytokines: What is their value as biomarkers for disease severity? Mem Inst Oswaldo Cruz 2005; 100:217-221. Epub 2005 Jun 2014
4. Sakr Y, Brunkhorst F, Burgett U, et al: Lipo-polysaccharide binding protein in a surgical ICU: A marker of sepsis ? Crit Care Med 2008; 36:2014-2022
5. Cunningham SC, Malone DL, Bochicchio GV, et al: Serum lipopolysaccharide-binding protein concentrations in trauma victims. Surg Infect (Larchmt) 2006; 7:251-261
6. Prucha M, Herold I, Zazula R, et al: Significance of lipopolysaccharide- binding protein (an acute phase protein) in monitoring critically ill patients. Crit Care 2003; 7:R154-159
7. Ubenauf KM, Krueger M, Henneke P, et al: Lipopolysaccharide binding protein is a potential marker for invasive bacterial infections in children. Pediatr Infect Dis J 2007; 26:159-162
8. Oude Nijhuis CS, Vellenga E, Daenen SM, et al: Lipopolysaccharide-binding protein: A possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients. Intensive Care Med 2003; 29:2157-2161. Epub 2003 Oct 2116
9. Lijmer JG, Mol BW, Heisterkamp S, et al: Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282:1061-1066
10. Christ-Crain M, Stolz D, Bingisser R, et al: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. Am J Respir Crit Care Med 2006; 174:84-93
11. Bozza FA, Salluh JI, Japiassu AM, et al: Cyto-kine profiles as markers of disease severity in sepsis: A multiplex analysis. Crit Care 2007; 11:R49
12. Povoa P: Serum markers in community-acquired pneumonia and ventilator-associated pneumonia. Curr Opin Infect Dis 2008; 21:157-162
13. Nobre V, Harbarth S, Graf JD, et al: Use of pro-calcitonin to shorten antibiotic treatment duration in septic patients: A randomized trial. Am J Respir Crit Care Med 2008; 177:498 -505
14. Ulloa L, Tracey KJ: The "cytokine profile": A code for sepsis. Trends Mol Med 2005; 11: 56-63
15. Dalton WS, Friend SH: Cancer biomarkers: An invitation to the table. Science 2006; 312: 1165-1168